Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation

Neurobiology of Disease

Volumn 34, Issue 1, 2009, Pages 71-77

  Belichenko, Nadia P ^a   Belichenko, Pavel V ^a   Mobley, William C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; MeCP2; Morphometry; Motor cortex; Mouse models; Rett syndrome; Spines

Indexed keywords

GREEN FLUORESCENT PROTEIN; METHYL CPG BINDING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; GENE; MALE; MECP2 GENE; MOUSE; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETT SYNDROME; STRUCTURE ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DENDRITIC SPINES; FEMALE; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MOTOR CORTEX; MUTATION; NEURONS; ORGAN SIZE; PHENOTYPE; SEX CHARACTERISTICS; X CHROMOSOME INACTIVATION;

EID: 62149119249     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.12.016     Document Type: Article

References (36)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
2. Armstrong D.D. The neuropathology of the Rett syndrome. Brain Dev. 14 Suppl (1992) S89-S98
3. Armstrong D.D. Neuropathology of Rett syndrome. J. Child Neurol. 20 (2005) 747-753
4. Armstrong D., Dunn J.K., Antalffy B., and Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol. 54 (1995) 195-201
5. Barbosa A.C., Kim M.S., Ertunc M., Adachi M., Nelson E.D., McAnally J., Richardson J.A., Kavalali E.T., Monteggia L.M., Bassel-Duby R., and Olson E.N. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9391-9396
6. Belichenko P.V., and Dahlström A. Mapping of the Human Brain in normal and pathology: the single cell and fiber level, employing Lucifer Yellow microinjection, carbocyanine dyes tracing, immunofluorescence, and 3-D confocal laser scanning reconstruction. Neurosci. Protocol. 50 3 (1995) 1-30
7. Belichenko P.V., Oldfors A., Hagberg B., and Dahlstrom A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. NeuroReport 5 (1994) 1509-1513
8. Belichenko P.V., Hagberg B., and Dahlstrom A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol. 93 (1997) 50-61
9. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., and Mobley W.C. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J. Comp. Neurol. 480 (2004) 281-298
10. Belichenko N.P., Belichenko P.V., Li H.H., Mobley W.C., and Francke U. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. J. Comp. Neurol. 508 (2008) 184-195
11. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., and Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008) 1224-1229
12. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27 (2001) 327-331
13. Danzer S.C., Pan E., Nef S., Parada L.F., and McNamara J.O. Altered regulation of brain-derived neurotrophic factor protein in hippocampus following slice preparation. Neuroscience 126 (2004) 859-869
14. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., and Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28 (2000) 41-51
15. Fiala J.C., Spacek J., and Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res. Brain Res. Rev. 39 (2002) 29-54
16. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27 (2001) 322-326
17. Hagberg B.A. Rett syndrome: clinical peculiarities, diagnostic approach, and possible cause. Pediatr. Neurol. 5 (1989) 75-83
18. Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr. 84 (1995) 971-976
19. Hagberg B., Aicardi J., Dias K., and Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14 (1983) 471-479
20. Hokfelt T., Stanic D., Sanford S.D., Gatlin J.C., Nilsson I., Paratcha G., Ledda F., Fetissov S., Lindfors C., Herzog H., Johansen J.E., Ubink R., and Pfenninger K.H. NPY and its involvement in axon guidance, neurogenesis, and feeding. Nutrition 24 (2008) 860-868
21. Jordan C., Li H.H., Kwan H.C., and Francke U. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med .Genet. 8 (2007) 36
22. Kantor D.B., Chivatakarn O., Peer K.L., Oster S.F., Inatani M., Hansen M.J., Flanagan J.G., Yamaguchi Y., Sretavan D.W., Giger R.J., and Kolodkin A.L. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44 (2004) 961-975
23. Kaufmann W.E., and Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 10 (2000) 981-991
24. Leontovich T.A., Mukhina J.K., Fedorov A.A., and Belichenko P.V. Morphological study of the entorhinal cortex, hippocampal formation, and basal ganglia in Rett syndrome patients. Neurobiol. Dis. 6 (1999) 77-91
25. McAllister A.K., Lo D.C., and Katz L.C. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15 (1995) 791-803
26. Metcalf B.M., Mullaney B.C., Johnston M.V., and Blue M.E. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience 139 (2006) 1449-1460
27. Miyamoto Y., Yamauchi J., Tanoue A., Wu C., and Mobley W.C. TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10444-10449
28. Nomura Y., and Segawa M. Natural history of Rett syndrome. J Child Neurol. 20 (2005) 764-768
29. Payer B., and Lee J.T. X chromosome dosage compensation: how mammals keep the balance. Annu. Rev. Genet. 42 (2008) 733-772
30. Percy A.K. Rett syndrome. Current status and new vistas. Neurol. Clin. 20 (2002) 1125-1141
31. Percy A.K. Rett syndrome: recent research progress. J. Child Neurol. 23 (2008) 543-549
32. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev., Neurosci. 2 (2001) 24-32
33. Rett A. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien. Med. Wochenschr. 116 (1966) 723-726
34. Smeets E., Schollen E., Moog U., Matthijs G., Herbergs J., Smeets H., Curfs L., Schrander-Stumpel C., and Fryns J.P. Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am. J. Med. Genet A. 122A (2003) 227-233
35. Wang H., Chan S.A., Ogier M., Hellard D., Wang Q., Smith C., and Katz D.M. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J. Neurosci. 26 (2006) 10911-10915
36. Young J.I., and Zoghbi H.Y. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet. 74 (2004) 511-520